General MedicationsINTRAVENOUSStandard
DAPTOMYCIN IN 0.9% SODIUM CHLORIDE
DAPTOMYCIN
Standard Dose
350MG/50ML (7MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DAPTOMYCIN IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 213645 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DAPTOMYCIN Form and strength SOLUTION;INTRAVENOUS - 350MG/50ML (7MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-04-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview DAPTOMYCIN IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 213645 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DAPTOMYCIN Form and strength SOLUTION;INTRAVENOUS - 350MG/50ML (7MG/ML) Sponsor BAXTER HLTHCARE CORP Submission history Latest submission status date: 2025-04-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.